The proposed rule targeted for December would force drugmakers to include all important risk information in an ad, a change the agency predicted will cost industry more than $100m annually.
The proposed rule targeted for December would force drugmakers to include all important risk information in an ad, a change the agency predicted will cost industry more than $100m annually.